- Home
- » Tags
- » Osaterone acetate
Top View
- Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös
- Cunto M, Mariani E, Anicito Guido E, Ballotta G, Zambelli D. Clinical Approach to 3 Prostatic Diseases in the Dog
- List of Medicinal Products and Withdrawal Periods
- Effect of Osaterone Acetate Administration on Prostatic Regression Rate, Peripheral Blood Hormone Levels and Semen Quality in Dogs with Benign Prostatic Hypertrophy
- (3) Trans-Abdominal Intra-Prostatic Injection of Ethanol And
- Concentrations of Canine Prostate Specific Esterase, CPSE, at Baseline Are Associated with the Relative Size of the Prostate at Three-Year Follow-Up Bodil S
- To Download Veterinary Practice February 2010
- New Drugs in Canine Reproduction
- Development of Synchrotron-Based Imaging Tools for Benign Prostatic Hyperplasia Using an Induced Canine Model
- Annual Report of the European Medicines Agency 2006
- Comparison of Clinical Effectiveness of Deslorelin Acetate And
- Remedies for Urinary Diseases Comprising Lpa Receptor Controlling Agents
- HITLIST1 Suspect List
- (12) Patent Application Publication (10) Pub. No.: US 2013/0251786 A1 Li Et Al
- Lääkeluettelon Liite 1. Läkemedelsförteckningen, Bilaga 1
- Composition and Lipid Formulation of a Hyaluronan-Degrading Enzyme And
- Top 5 Reproduction Concerns in Dogs
- Lääkeluettelon Aineet, Liite 1
- SCIENTIFIC DISCUSSION 1. INTRODUCTION Ypozane Tablets Contain the Active Substance Osaterone Acetate and Are Indicated for the T
- Prostatic Disorders in the Dog Dr
- Ypozane,INN-Osaterone Acetate
- (12) United States Patent (10) Patent No.: US 7,288,558 B2 Nakade Et Al
- Veterinary Practice